Volume 8.32 | Aug 14

ESC & iPSC News 8.32 August 14, 2013
ESC & iPSC News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  ESC & iPSC News on Twitter
 
TOP STORY
Generation of Tumor-Targeted Human T Lymphocytes from Induced Pluripotent Stem Cells for Cancer Therapy
Scientists combined induced pluripotent stem cell and chimeric antigen receptor technologies to generate human T cells targeted to CD19, an antigen expressed by malignant B cells, in tissue culture. [Nat Cell Biol] Abstract
Brain Food: NeuroCult SM1 for Long-Term Primary Neuronal Culture
 
PUBLICATIONS (Ranked by impact factor of the journal)
Establishment of Totipotency Does Not Depend on Oct4A
Researchers genetically eliminated maternal Oct4A using a Cre/loxP approach in mouse and found that the establishment of totipotency was not affected, as shown by the generation of live pups. [Nat Cell Biol] Abstract

The Mll2 Branch of the COMPASS Family Regulates Bivalent Promoters in Mouse Embryonic Stem Cells
Although Polycomb repressive complex 2 is known to implement H3K27 trimethylation, the COMPASS family member responsible for H3K4me3 at bivalently marked promoters was previously unknown. Scientists identified Mll2 as the enzyme catalyzing H3K4 trimethylation at bivalently marked promoters in embryonic stem cells. [Nat Struct Cell Biol] Abstract | Press Release

Single-Cell RNA-Seq Profiling of Human Preimplantation Embryos and Embryonic Stem Cells
Investigators applied single-cell RNA sequencing (RNA-Seq) analysis to 124 individual cells from human preimplantation embryos and human embryonic stem cells at different passages. [Nat Struct Cell Biol] Abstract

Repopulation of Decellularized Mouse Heart with Human Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells
Scientists created heart constructs by repopulating decellularized mouse hearts with human induced pluripotent stem cell-derived multipotential cardiovascular progenitor cells. They showed that the seeded multipotential cardiovascular progenitor cells migrate, proliferate and differentiate in situ into cardiomyocytes, smooth muscle cells and endothelial cells to reconstruct the decellularized hearts. [Nat Commun] Abstract | Press Release

Erg Channel Is Critical in Controlling Cell Volume during Cell Cycle in Embryonic Stem Cells
Following RNAseq transcriptome analysis of cell cycle sorted mouse embryonic stem cells, the authors found that expression of the K+ ion channel Erg1 peaked in G1 cell cycle phase, which was confirmed by immunostaining. [PLoS One] Full Article

Evidence for a Critical Role of Catecholamines for Cardiomyocyte Lineage Commitment in Murine Embryonic Stem Cells
Investigators evaluated the effects of different catecholamines on early heart development in an in vitro setting using embryonic stem (ES) cell-derived cardiomyocytes. Effects of catecholamine depletion induced by reserpine were examined in murine ES cells during differentiation. [PLoS One] Full Article

Seamless Correction of the Sickle Cell Disease Mutation of the Human β-Globin Gene in Human Induced Pluripotent Stem Cells Using TALENs
Researchers successfully utilized transcription activator-like effector nucleases (TALENs), a recently emerged novel genome editing tool, to correct the sickle cell disease mutation in patient-derived human induced pluripotent stem cells. [Biotechnol Bioeng] Abstract

Angiotensin II Promotes Cardiac Differentiation of Embryonic Stem Cells via Angiotensin Type 1 Receptor
The authors demonstrated that angiotensin type 1 receptor agonist significantly enhanced cardiac differentiation as determined by increased percentage of beating embryoid bodies and a higher expression level of cardiac markers. [Differentiation] Abstract

Kinetics of Drug Selection Systems in Mouse Embryonic Stem Cells
Investigators quantitatively measured the variation of transgene expression levels in mouse embryonic stem cells, using a series of bi-cistronic expression vectors that contain Egfp expression cassette linked to each drug resistant gene via IRES with titration of the selective drugs, and found that the transgene expression levels achieved in each system with this vector design are in order, in which pac and zeo show sharp selection of transfectants with homogenously high expression levels. [BMC Biotechnol]
Abstract | Full Articles

New: STEMdiff™ Definitive Endoderm Kit For Easy, Standardized hPSC Differentiation
 
REVIEWS
Toward Directed Reprogramming through Exogenous Factors
Various exogenous factors, especially small molecules modulating signaling, cellular state, and transcription, have been identified to enhance and enable reprogramming. With an increased understanding of reprogramming mechanisms and discovery of new molecules, it is conceivable that reprogramming can be achieved in a more directed and deterministic manner under entirely chemically defined conditions. [Curr Opin Genet Dev] Abstract

Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field.
 
INDUSTRY NEWS
Athersys Announces Grant to Support Clinical Advancement of Its MultiStem® Regenerative Medicine Program for Heart Attack Patients
Athersys, Inc. announced that it has received a SBIR Fast Track grant from the National Heart, Lung, and Blood Institute, which will support a Phase II clinical study evaluating the administration of MultiStem® therapy to patients who have suffered a heart attack, or acute myocardial infarction. [Athersys Inc.] Press Release

Pilot Clinical Study into iPS Cell Therapy for Eye Disease Starts in Japan
RIKEN announced the launch of a pilot study to assess the safety and feasibility of the transplantation of autologous induced pluripotent stem (iPS) cell-derived retinal pigment epithelium cell sheets in patients with exudative age-related macular degeneration. [RIKEN] Press Release

Stem Cell Society Singapore 2013 Symposium
 
POLICY NEWS
Famous HeLa Cells Get Genetic Close-Up, and New Data-Sharing Rules
Five months after it was hastily removed from the Internet in the face of harsh criticism, the genome of the widely used HeLa cell line is back online. Not only that, but it is also now sequenced at the highest level of resolution yet for a cancer research cell line. But scientists who want to use those data must now ask for permission from a committee that includes descendants of the woman whose cells were taken – without her consent – 62 years ago. [U.S. National Institutes of Health] Press Release

House Panel Trains Sights on Unregulated Stem-Cell Therapy in the Philippines
The vice chairman of the House blue-ribbon panel is set to deliver a privileged speech Monday ahead of hearings on the current state of things in the stem cell therapy practice in the Philippines, where experts warned earlier the “fad-like” atmosphere poses serious threat to public health and safety. [Congress of the Philippines] Press Release

New wallchart from our sponsor:
Mesenchymal Stem Cells (a Nature Reviews Molecular Cell Biology collaboration). Request your free copy.
 
EVENTS
NEW Genetic Engineering of Mammalian Stem Cells
March 10-22, 2014
Cambridge, United Kingdom

Visit our events page to see a complete list of events in the ESC & iPSC community.
 
JOB OPPORTUNITIES
NEW Research Technologist – Human Pluripotent Stem Cell Products (STEMCELL Technologies Inc.)

NEW Research Associate – Human Induced Pluripotent Stem Cell Initiative (King’s College London)

Postdoctoral Position – Neurosteroids and Neural Stem Cells in Developing Brain (Children’s National Medical Center)

Tenure-Track Position – Cell Biologist (McGill University)

Postdoctoral Fellow – Human Stem Cell Biology and Hematopoiesis (Johns Hopkins University School of Medicine)

Stem Cell Researcher – Heart Research Group (University of Tampere)

Postdoctoral Position – Stem Cell Therapy and Epigenetics of Retina (University of Pittsburgh, Ophthalmology)

Director of Cell Processing Facility (S L Collins Associates, Inc.)


Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Learn more about ESC & iPSC News: Archives | Events | Contact Us